StockData
Lifevantage Corp logo

Lifevantage Corp (LFVN) stock

LFVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 20/3044% below fair value
$4.78+0.01 (+0.21%)

Close on Nov 17, 2026Market cap $59.88MP/E 11.9Yield 3.87%

Lifevantage market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Lifevantage's market cap was $59.08M on Nov 11, 2026, against $87.19M a year earlier. Over the last 5 years it ranged from $41.93M to $264.16M, with a median of $78.86M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$59.08M-24.4%
2025Dec 31, 2025$78.18M-64.3%
2024Dec 31, 2024$218.84M+187.0%
2023Dec 29, 2023$76.24M+63.2%
2022Dec 30, 2022$46.72M-44.1%
2021Dec 31, 2021$83.65M-37.0%
2020Dec 31, 2020$132.70M-39.4%
2019Dec 31, 2019$219.07M+17.8%
2018Dec 31, 2018$186.02M+174.7%
2017Dec 29, 2017$67.73M-40.9%
2016Dec 30, 2016$114.58M-13.9%
2015Dec 31, 2015$133.10M+1.6%
2014Dec 31, 2014$131.06M-32.5%
2013Dec 31, 2013$194.23M-21.4%
2012Dec 31, 2012$247.14M+74.1%
2011Dec 30, 2011$141.97M–

More Lifevantage figures

See a number that looks wrong?